✦ LIBER ✦

Long-Term Followup of all Patients with Muscle Invasive (Stages T2, T3 and T4) Bladder Carcinoma in a Geographical Region

✍ Scribed by Holmang, Sten; Hedelin, Hans; Anderstrom, Claes; Johansson, Sonny L.

Book ID: 123007502
Publisher: Lippincott Williams and Wilkins
Year: 1997
Tongue: English
Weight: 505 KB
Volume: 158
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)64486-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bladder conservation in selected T1G3 an

Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation

✍ L. M. F. MOONEN; S. HORENBLAS; J. C. M. Van der VOET; M. J. C. NUYTEN; H. BARTEL 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

C92 THE EFECT OF MUSCLE INVASION DEPTH O

C92 THE EFECT OF MUSCLE INVASION DEPTH ON SURVIVAL RATES IN PATIENTS WITH PATHOLOGICAL STAGE T2A AND T2B INVASIVE UROTHELIAL BLADDER CANCER

✍ C. Kara; U. Balci; K. Ozer; S. Ozbir; C. Girgin; C. Dincel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Tumor size predicts the survival of pati

Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma : A critical evaluation of the depth of muscle invasion

✍ Liang Cheng; Roxann M. Neumann; Beth G. Scherer; Amy L. Weaver; Bradley C. Leibo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

## BACKGROUND. Accurate examination of radical cystectomy specimens is critical for stratifying patients into prognostically important groups and determining the need for adjuvant treatment. Evidence has accumulated that cancers invading the superficial muscle wall (T2a) behave similarly to those

Breast-Conserving Therapy in Patients Wi

Breast-Conserving Therapy in Patients With a Relatively Large (T2 or T3) Breast Cancer: Long-term Local Control and Cosmetic Outcome of a Feasibility Study

✍ Kronowitz, S.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

LONG-TERM EFFICACY RESULTS OF EORTC GU G

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTE- GUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 BLADDER CARCINOMA

✍ Sylvester, Richard; Brausi, Maurizio; Hoeltl, Wolfgang; Powell, Philip; Whelan, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 138 KB

Prognostic Factors and Risk Groups in T1

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

✍ Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven; Vander Ee 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 470 KB